A Caenorhabditis elegans ortholog of human selenium-binding protein 1 is a pro-aging factor protecting against selenite toxicity

Journal Pre-proof A Caenorhabditis elegans ortholog of human selenium binding protein 1 is a proaging factor protecting against selenite toxicity Karl Köhnlein, Nadine Urban, David Guerrero-Gómez, Holger Steinbrenner, Pavel Urbánek, Josephine Priebs, Philipp Koch, Christoph Kaether, Antonio MirandaVizuete, Lars-Oliver Klotz PII:

S2213-2317(19)30841-9

DOI:

https://doi.org/10.1016/j.redox.2019.101323

Reference:

REDOX 101323

To appear in:

Redox Biology

Received Date: 19 July 2019 Revised Date:

30 August 2019

Accepted Date: 7 September 2019

Please cite this article as: K. Köhnlein, N. Urban, D. Guerrero-Gómez, H. Steinbrenner, P. Urbánek, J. Priebs, P. Koch, C. Kaether, A. Miranda-Vizuete, L.-O. Klotz, A Caenorhabditis elegans ortholog of human selenium binding protein 1 is a pro-aging factor protecting against selenite toxicity, Redox Biology (2019), doi: https://doi.org/10.1016/j.redox.2019.101323. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier B.V.

1

A Caenorhabditis elegans ortholog of human selenium binding protein 1 is a pro-aging

2

factor protecting against selenite toxicity

3 4

Karl Köhnleina,c#, Nadine Urbana#, David Guerrero-Gómezb, Holger Steinbrennera, Pavel

5

Urbáneka,1, Josephine Priebsa, Philipp Kochc, Christoph Kaetherc, Antonio Miranda-Vizueteb,

6

Lars-Oliver Klotza*

7 8

a

9

Jena, Germany

Institute of Nutritional Sciences, Nutrigenomics Section, Friedrich-Schiller-Universität Jena,

10

b

11

Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain

12

c

Leibniz Institute on Aging - Fritz Lipmann Institute, Jena, Germany

#

Authors contributed equally

Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del

13 14 15 16

*Address correspondence to:

17

Dr. Lars-Oliver Klotz

18

Institute of Nutritional Sciences, Nutrigenomics Section, Friedrich Schiller University Jena

19

Dornburger Strasse 29, D-07743 Jena, Germany

20

Tel.: +49-3641-949750

21

Fax: +49-3641-949752

22

E-mail: [email protected]

23 24 25 26

1

Present address: Leibniz Institute on Aging - Fritz Lipmann Institute, Jena, Germany

27

1

28

Abstract

29

Human selenium binding protein 1 (SELENBP1) was originally identified as a protein binding

30

selenium, most likely as selenite. SELENBP1 is associated with cellular redox and thiol

31

homeostasis in several respects, including its established role as a methanethiol oxidase that

32

is involved in degradation of a methionine catabolite, generating hydrogen sulfide (H2S) and

33

hydrogen peroxide (H2O2). As both H2S and reactive oxygen species (such as H2O2) are major

34

regulators of Caenorhabditis elegans lifespan and stress resistance, we hypothesized that a

35

SELENBP1 ortholog in C. elegans would likely be involved in regulating these aspects.

36

Here we characterize Y37A1B.5, a putative SELENBP1 ortholog in C. elegans with 52%

37

primary structure identity. While conferring resistance to toxic concentrations of selenite,

38

Y37A1B.5 also attenuates resistance to oxidative stress and lowers C. elegans lifespan:

39

knockdown of Y37A1B.5 using RNA interference resulted in an approx. 10% increase of C.

40

elegans lifespan and an enhanced resistance against the redox cycler paraquat, as well as an

41

enhanced motility. Analyses of transgenic reporter strains suggest hypodermal expression

42

and cytoplasmic localization of Y37A1B.5, whose expression decreases with worm age. We

43

identify the transcriptional coregulator MDT-15 and transcription factor EGL-27 as regulators

44

of Y37A1B.5 levels and show that the lifespan extending effect elicited by downregulation of

45

Y37A1B.5 is independent of known MDT-15 interacting factors, such as DAF-16 and NHR-49.

46

In summary, Y37A1B.5 is an ortholog of SELENBP1 that shortens C. elegans lifespan and

47

lowers resistance against oxidative stress, while allowing for a better survival under toxic

48

selenite concentrations.

49 50 51

Key words: selenium binding protein, stress signaling, Caenorhabditis elegans, lifespan

52

2

53

Introduction

54

Selenium (Se) is an essential trace element for humans and animals that is biologically active

55

mostly in the form of selenocysteine built into selenoproteins. The human selenoproteome

56

consists of 25 selenoproteins and includes five glutathione peroxidase (GPx), three

57

thioredoxin reductase (TrxR) and one methionine sulfoxide reductase (Msr) isoform(s),

58

which are involved in the removal of reactive oxygen species (ROS) such as hydroperoxides,

59

the repair of oxidized methionine residues in proteins and the maintenance of cellular and

60

systemic redox homeostasis [1-3]. Adequate Se intake has been associated with protection

61

against oxidative stress-related adverse conditions and diseases such as cancer or

62

inflammatory disorders in humans. On the other hand, oversupply with Se causes toxicity, as

63

compounds with Se in the oxidation state -2 may undergo redox cycling and thus act as “pro-

64

oxidants” [1-3].

65

The nematode Caenorhabditis elegans is an interesting case with respect to selenoprotein

66

and Se biochemistry: whereas the human genome encodes a total of 25 selenoproteins [4],

67

C. elegans has only one selenoprotein, thioredoxin reductase-1 (TRXR1) [5, 6]. Although C.

68

elegans expresses a functional machinery allowing for incorporation of selenocysteine into

69

this single protein, deletion of the trxr-1 gene does not only not shorten C. elegans lifespan

70

[7], but also does not affect sensitivity of C. elegans towards toxic effects of inorganic Se

71

compounds on survival, growth and development [8, 9]. While trxr-1-deficient nematodes

72

contain considerably less Se compared to wild-type C. elegans when grown under basal

73

conditions without Se supplementation, both strains incorporate Se with similar efficiency

74

upon exposure to selenite [9]. Two further types of Se-containing proteins were described in

75

mammalian cells, those that have non-specifically incorporated selenomethionine instead of

76

methionine and the small group of selenium-binding proteins [10]. The most prominent of

77

the latter is selenium-binding protein 1 (SELENBP1), originally identified as a protein binding

78

Se, most likely as selenite [11]. Neither the mode of selenite binding nor the physiological

79

significance of SELENBP1 have been fully elucidated. Nevertheless, some associations with

80

(patho-)physiological processes were described, including a link to cell differentiation [12,

81

13] and a correlation between low SELENBP1 expression levels in tumor tissue and poor

82

clinical outcome (for review, see [14]).

3

83

Interestingly, SELENBP1 is associated with cellular redox and thiol homeostasis in several

84

respects: (i) specific cysteine residues in SELENBP1 were proposed to mediate selenite

85

binding or the interaction with metal ions [15, 16]; (ii) SELENBP1 expression was found to be

86

inversely related to activity and/or expression of the major antioxidant selenoenzyme GPx1

87

[14, 17]; (iii) SELENBP1 was also shown to be involved in controlling the export of

88

glutathione (GSH) from breast cancer cells and thereby affecting cellular resistance against

89

oxidative stress [17]; (iv) lastly, a unique enzymatic activity of SELENBP1 was recently

90

identified [18]. It is a methanethiol oxidase generating hydrogen sulfide (H2S) and hydrogen

91

peroxide (H2O2) from a bacterial methionine degradation product, methyl mercaptan

92

(methanethiol). Both H2S and ROS (such as H2O2) [19] as well as, more generally, redox

93

processes and thiol metabolism [20] are major regulators of C. elegans lifespan and stress

94

resistance. Therefore, we hypothesized that a SELENBP1 ortholog in C. elegans would likely

95

be involved in regulating these aspects.

96

We here describe Y37A1B.5, a putative C. elegans ortholog of human SELENBP1, and define

97

its role in regulating stress resistance and lifespan.

98

99

Materials and Methods

100

Materials

101

Chemicals were purchased from Sigma-Aldrich (Munich, Germany) or Carl Roth (Karlsruhe,

102

Germany), unless stated otherwise. Primers were obtained from Life Technologies

103

(Darmstadt, Germany).

104 105

C. elegans maintenance and treatments

106

C. elegans strains were provided by the Caenorhabditis Genetics Center (CGC, University of

107

Minnesota, USA), which is supported by the National Institutes of Health-Office of Research

108

Infrastructure Programs. The following strains were used: wild-type Bristol N2; EU31, skn-

109

1(zu135) IV; CF1038, daf-16(mu86) I; RB1716, nhr-49(ok2165) I. E. coli OP50 was also

110

received from CGC. For knockdown experiments, RNAi clones were derived from the

111

Ahringer library (Source BioScience, Nottingham, UK) [21] and grown using the appropriate 4

112

antibiotics. Nematodes were grown, maintained and treated at 20°C on nematode growth

113

medium (NGM) agar plates spotted with E. coli OP50 as food source, as described elsewhere

114

[22]. For stress resistance assays, heat-inactivated bacteria (45 min at 65°C) were used.

115

Synchronized worm populations were used in all experiments. To this end, worms were

116

washed off the plates, then the eggs collected and washed by centrifugation in sterile

117

ultrapure H2O. Eggs were transferred to fresh NGM agar plates and allowed to hatch and

118

grow for 64 h to young adulthood before being transferred to fresh plates for further

119

experiments. For long-term incubations, nematodes were washed off the plates with S-basal

120

buffer daily and were transferred to freshly prepared NGM agar plates to separate

121

nematodes from progeny. Experiments were carried out with young adult worms, 64 h after

122

synchronization, except for two experiments with exposure to RNAi from egg (see Table 2).

123

For RNAi experiments, 1 mM isopropyl-β-D-thiogalactoside (IPTG), 100 µg/ml ampicillin and,

124

if necessary, 12.5 μg/ml tetracycline were added to NGM agar. On the evening before the

125

experiment, agar plates were spotted with E. coli HT115 containing the L4440 empty vector

126

(RNAi control) or the respective DNA fragment cloned into the L4440 vector and allowed to

127

dry overnight.

128

For selenite toxicity assays, worms were treated with Y37A1B.5 RNAi starting at the egg

129

stage for 72 h. Worms were then exposed to sodium selenite (0, 10, 20 or 30 mM) for 17h in

130

150µl of heat-inactivated bacteria suspension and shaken at 900 rpm on an orbital shaker.

131

The assay was performed in triplicates in a 96-well format. After 17 h, viability was scored

132

after transfer onto NGM plates.

133 134

Lifespan assays

135

Lifespan analyses of nematodes under RNAi conditions were performed using E. coli HT115

136

containing either L4440 empty vector (control) or the respective DNA fragment in L4440

137

starting at young adult stage. For the first 10 days, nematodes were transferred to fresh

138

plates daily; thereafter, they were transferred every other day. Worms showing no

139

movement, no reaction to gentle stimulation and no pharyngeal pumping were scored as

140

dead. Worms lost or disintegrated, e.g. due to internal hatchings, were censored.

141

Experiments were performed in several technical replicates (usually quintuplicates). 5

142 143

Stress resistance assays

144

Following RNAi or control treatment for five days, worms were exposed to the redox cycler

145

paraquat. For paraquat exposure, worms were transferred to plates spotted with heat-

146

inactivated bacteria and containing 300 mM paraquat; survival was scored hourly.

147 148

Assessment of locomotion, body area and body length

149

Nematodes were exposed to RNAi or control treatment for five (body area, length) or ten

150

(locomotion) days.

151

On day five, 10 nematodes were transferred to S-basal with 0.1% Triton X-100. Worms were

152

pipetted onto an objective slide and photographs of single worms were taken on an inverted

153

Nikon Eclipse Ti-E fluorescence microscope. Each photograph was analyzed using the Nikon

154

software NIS elements. Ten worms were analyzed for each treatment group, and the

155

experiment was performed at least three times.

156

On day ten, single nematodes were transferred to S-basal medium containing 0.1% Triton X-

157

100. Single worms were then pipetted, in a drop of 1 µl S-basal, onto an objective slide, and

158

10-second-movies were recorded under an inverted Nikon Eclipse Ti-E fluorescence

159

microscope. For each treatment group, 10 worms were recorded, and the experiment was

160

performed at least three times. Pathlength analysis was performed using Nikon tracking

161

software (NIS elements).

162 163

Fecundity

164

64 h after synchronization, ten single nematodes of each treatment group were each

165

transferred to one NGM RNAi agar plate to lay eggs. 24 h later the ten worms were

166

transferred to ten new agar plates spotted with the respective bacteria and again allowed to

167

lay eggs. The procedure was repeated until nematodes ceased to lay eggs. Each time, after

168

transfer of worms, the remaining plates and eggs were placed back to the incubator. Worms

169

(progeny) were allowed to hatch and grow until reaching the L3 larvae stage (48 h) and then

170

counted. The experiment was performed three independent times. 6

171 172

Quantitative reverse transcription-PCR (qRT-PCR)

173

Worms were collected and shock-frozen in liquid nitrogen. Worms were lysed in TRIzol

174

reagent (Thermo Scientific) and total RNA was isolated using acid guanidinium thiocyanate-

175

phenol-chloroform extraction. RNA (1 µg) was reversely transcribed using GoScript Reverse

176

Transcriptase (Promega) or RevertAid Reverse Transcriptase (Thermo Scientific), according

177

to the manufacturers’ instructions, and subjected to qPCR analysis using SsoAdvanced

178

Universal SYBR Green Supermix and a CFX Connect cycler (Bio-Rad Laboratories AG, Munich,

179

Germany). Experiments were conducted in triplicates. cdc-42, tba-1 or pmp-3 were used as

180

housekeeping genes for relative quantitation of mRNAs of interest [23]. Sequences of

181

primers used for PCR are compiled in Table 1.

182 183

RNA sequencing (RNA-Seq)

184

Sequencing of RNA samples was done following their reverse transcription using Illumina’s

185

next-generation sequencing methodology [24]. Specifically, quality check and quantification

186

of total RNA was done using the Agilent Bioanalyzer 2100 in combination with the RNA 6000

187

nano kit (Agilent Technologies). Approximately 1 µg of total RNA was used for library

188

preparation using the TruSeq stranded mRNA library preparation kit (Illumina) following the

189

manufacturer’s description. Quantification and quality check of libraries was done using the

190

Agilent Bioanalyzer 2100 in combination with the DNA 7500 kit. Libraries were sequenced on

191

a HiSeq2500 running in 51cycle/single-end/high-output mode using sequencing chemistry

192

v3. All libraries were pooled and sequenced in three lanes. Sequence information was

193

extracted in FastQ format using Illumina’s bcl2fastq v.1.8.4. Sequencing resulted in around

194

40 ± 4 million reads per sample.

195 196

RNA expression analysis

197

For expression analysis, the raw RNA-Seq reads were quality-trimmed and filtered for low

198

complexity with the tool preprocess from the SGA assembler (version 0.10.13, parameters -q

199

30 -m 50 --dust) [25]. The passed reads were mapped to the C. elegans genome (WBcel235,

200

release 90, http://aug2017.archive.ensembl.org/Caenorhabditis_elegans/Info/Annotation) 7

201

with Ensembl gene annotation using TopHat2 (version 2.1.0; conservative settings, i.e --b2-

202

sensitive --no-coverage-search --no-novel-juncs --no-novel-indels --transcriptome-max-

203

hits=1) [26]. Next, all reads mapping uniquely to an Ensembl gene were counted using

204

FeatureCounts (version 1.5.0; multi-mapping or multi-overlapping reads were not counted,

205

stranded mode was set to “–s 2”, Ensembl release 90 gene annotation) [27].

206

The table of raw counts per gene per sample was analyzed with R (version 3.4.1) using the

207

package DESeq2 (version 1.16.1) [28] to test for differential expression. Y37A1B.5 RNAi

208

samples were contrasted with the control samples (L4440 empty vector). For each gene of

209

the comparison, the p-value was calculated using the Wald significance test. Resulting p-

210

values were adjusted for multiple testing with Benjamini & Hochberg correction. Genes with

211

an adjusted p-value <0.05 are considered differentially expressed (DEGs). The log2-fold

212

changes (LFC) were shrunken with lfcShrink to control for variance of LFC estimates for

213

genes with low read counts.

214 215

Pathway enrichment

216

For the identification of enriched pathways, DEGs were entered in the GEne SeT AnaLysis

217

Toolkit "WebGestalt" (www.webgestalt.org) as a ranked list, with the LFC representing the

218

rank for each DEG. As a threshold for significantly enriched pathways FDR was set to 0.05.

219

We performed Gene Set Enrichment Analysis (GSEA) using the KEGG pathway database for

220

C. elegans. The normalized enrichment score (NES) displays positively (black) and negatively

221

(grey) related categories which corresponds to up- or downregulated pathways.

222 223

Generation of transgenic strains

224

For the generation of a Y37A1B.5 translational reporter construct, a region of 2988 bp

225

upstream of the translation initiation codon ATG (promoter region) and the complete

226

genomic coding sequence of the Y37A1B.5 gene (excluding the translation termination

227

codon) were amplified as a single PCR-fragment from the N2 wildtype worm genomic DNA,

228

using primers with pre-designed BamHI and Cfr9I restriction enzyme sites (see Fig. 3A). The

229

amplified region was digested using BamHI and Cfr9I and inserted into the pPD95_77 empty

230

vector at the BamHI and XmaI sites. pPD95_77 was a gift from Andrew Fire (Addgene 8

231

plasmid #1495; http://n2t.net/addgene:1495; RRID:Addgene_1495). The final construct

232

PY37A1B.5:: Y37A1B.5::gfp was injected into the N2 wildtype strain at 20 ng/µl along with

233

the rol-6(su1006) coinjection marker at 50 ng/µl. Stable transmitting lines were used for

234

image analysis.

235 236

Fluorescence microscopy

237

Adult nematodes were placed on microscope slides coated with 3% agarose, anaesthetized

238

with 10 mM sodium azide, and covered with coverslips. GFP fluorescence was analyzed on a

239

Nikon Eclipse Ti-E fluorescence microscope using appropriate filters (GFP: ex. 472±30 nm,

240

em. 520±35 nm). Pictures to determine localization were taken on a Zeiss Axio Imager.Z2

241

microscope. For quantitation of the GFP signal intensity, worms were marked as regions of

242

interest (ROI) – either automatically using the binary threshold of the GFP signal or manually

243

using the brightfield overlay image. Total GFP intensity and area of each ROI was then

244

measured and GFP intensity was normalized to worm area and subtracted from background

245

signal to obtain the relative GFP fluorescence intensity for each worm.

246

For analysis of GFP expression under stress, nematodes showing the roller phenotype were

247

transferred to plates that were spotted with heat-inactivated bacteria containing the

248

respective compound. 24 h later, GFP expression in those worms was analyzed as described

249

above.

250 251

Statistical analysis

252

Data are expressed as means + SD unless stated otherwise. For lifespan analyses, statistical

253

calculations were performed using JMP software (SAS Institute Inc., Cary, NC, USA), applying

254

the log-rank test. Median and mean survival was calculated by log-rank test for each of the

255

technical replicates in one experiment (i.e. biological replicate). Maximum lifespan in each

256

technical replicate was defined as the last day on which a worm was scored as alive. Mean

257

maximum lifespan for each biological replicate was then determined as the mean of all

258

technical replicates. All other calculations were performed using GraphPad Prism (GraphPad

259

Software, San Diego, California, USA). Statistical significances were calculated using one-way

9

260

ANOVA (Bonferroni), Mann-Whitney test (for data in Figure 4B), or t-test where appropriate.

261

The minimum level of significance was set to p < 0.05.

262 263

Data Availability

264

The data discussed in this publication have been deposited in NCBI's Gene Expression

265

Omnibus [29] and are accessible through GEO Series accession number GSE134196

266

(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134196).

267

268

Results and Discussion

269

Y37A1B.5 is a C. elegans ortholog of SELENBP1, affecting stress resistance and lifespan

270

We conducted a BLAST search of the C. elegans non-redundant protein sequence

271

database for homologs of human SELENBP1 (GenBank accession# CAG33133). Y37A1B.5 is

272

the C. elegans protein most similar in primary structure to SELENBP1, with 52% identity in

273

amino acid sequence. Several conserved regions were identified by multiple sequence

274

alignment of Y37A1B.5 with human SELENBP1 and its homologs in two other non-

275

mammalian species, Drosophila melanogaster and Danio rerio (Figure 1). One example is

276

Cys57, corresponding to Cys57 in SELENBP1 (highlighted in black in Figure 1). Cys57 was

277

hypothesized to be involved in Se binding [15] and demonstrated to be a crucial determinant

278

of stability and effects of overexpressed SELENBP1 in cultured cells [30]. Further conserved

279

motifs include a thioredoxin motif [31, 32] present at the active site of redoxin family

280

proteins (CxxC, transparent box in Figure 1) [33], and histidine-containing metal binding

281

motifs (HxD, HxxH, gray background in Figure 1) [32, 34].

282

Next, we tested whether expression of Y37A1B.5 may be altered in relation to worm age,

283

and whether it affects C. elegans lifespan. For this purpose, we determined Y37A1B.5 mRNA

284

levels during the course of C. elegans adulthood, followed by analysis of the consequences

285

of Y37A1B.5 knockdown by RNA interference (RNAi).

286

Y37A1B.5 gene expression exponentially declines over the course of C. elegans adulthood,

287

i.e. from the first day of adulthood to 20 days post adulthood (Figure 2 A, B). Depletion of

288

Y37A1B.5 through RNAi, i.e. imitation of the later-age situation with respect to Y37A1B.5 10

289

expression, resulted in an enhanced lifespan (Figure 2C), with a significant extension of both

290

mean and maximum lifespan (Figure 2D; see Table 2 for details). Using RNAi, we achieved

291

Y37A1B.5 knockdown to yield mRNA levels of approx. 10 % of control (2 and 13% on days 3

292

and 5, respectively; Figure 2E).

293

These data suggest that, whereas Y37A1B.5 expression may be dispensable for C. elegans at

294

a later age, it appears to be required in early life, as knockdown of Y37A1B.5 from egg does

295

not lead to an unambiguous (reproducible) extension of lifespan, although no overt adverse

296

effects of deficiency were noticed either (Table 2). The data also suggest that expression of

297

Y37A1B.5 comes at a cost, as knocking down Y37A1B.5 in young adults causes an extension

298

of lifespan.

299

We therefore thought about potential beneficial effects of Y37A1B.5. As SELENBP1 was

300

originally detected as a protein binding Se in mice injected with high doses of selenite [11],

301

we tested for the role of Y37A1B.5 in C. elegans exposed to 10, 20 or 30 mM selenite, which

302

was shown before to be a concentration range toxic to the nematodes [9]. As demonstrated

303

in Figure 2F, C. elegans is significantly more sensitive to selenite at all tested concentrations

304

upon knockdown of Y37A1B.5 by RNAi, suggesting a protective role of the protein against

305

acutely toxic Se exposure.

306

In summary, Y37A1B.5 is an ortholog of human SELENBP1 that protects C. elegans against

307

selenite toxicity. Conversely, its downregulation enhances C. elegans lifespan.

308 309

Y37A1B.5 is a cytoplasmic protein predominantly expressed in hypodermal cells

310

We then set out to further characterize the expression pattern of Y37A1B.5 and the

311

physiological consequences thereof in the absence of added Se. To this end, we generated a

312

translational fusion construct harboring 3 kb of Y37A1B.5 endogenous promoter region plus

313

the complete ORF fused to GFP at the C-terminus (pY37A1B.5::Y37A1B.5::GFP), as depicted

314

in Figure 3A. Microscopic analysis of adult transgenic worms shows that GFP fluorescence is

315

most prominent in hypodermal cells (Figure 3B). Subcellularly, Y37A1B.5::GFP is found

316

predominantly in the cytoplasm (Figure 3C), which is true also for human SELENBP1 [12].

317

Sporadically, in few worms only, GFP fluorescence is also detected in some anterior or

318

posterior intestinal cells (Figure 3D). 11

319

As demonstrated in Figure 3E, the RNAi approach chosen to analyze the effect of Y37A1B.5

320

on lifespan (Figure 2) also effectively downregulated expression of the transgenic fusion

321

protein as indicated by attenuated overall Y37A1B.5::GFP fluorescence.

322 323

Depletion of Y37A1B.5 enhances stress resistance and improves physiological parameters

324

In order to test whether the extended lifespan of worms following Y37A1B.5

325

downregulation was accompanied by enhanced resistance to stressful stimuli other than

326

selenite, we exposed the nematodes to a lethal dose (300 mM) of the redox cycler paraquat.

327

Surprisingly, and in contrast to the selenite exposure, after RNAi treatment for six days,

328

Y37A1B.5-deficient worms exhibited a significantly better survival under paraquat exposure

329

than worms fed with control RNAi (Figures 4A, 4B; for details, see Table 3).

330

Exposure of pY37A1B.5::Y37::gfp transgenic worms to another stressful stimulus, arsenite,

331

elicited an attenuation of Y37A1B.5::GFP expression (Figure 4C, 4D), suggesting that

332

downregulation of Y37A1B.5 may be part of a general C. elegans stress response.

333

In line with their elevated stress resistance to paraquat and extended lifespan, the

334

Y37A1B.5-deficient worms generally appeared to be healthier than their wild-type

335

counterparts, particularly at older age. This was indicated also by the improved C. elegans

336

motility upon knockdown of Y37A1B.5 (Figure 5A). No impairment of C. elegans fecundity

337

was observed under these conditions (Figure 5B), and there was a trend towards an

338

increased body area and length, particularly at later stages (Figure 5C, 5D).

339 340

Analysis of Y37A1B.5 knockdown-induced transcriptome changes

341

In order to investigate the role of Y37A1B.5 in C. elegans metabolism, we performed

342

gene expression analysis using RNA-Seq. RNA was isolated from C. elegans fed with bacteria

343

expressing the empty RNAi vector L4440 or a Y37A1B.5-specific RNAi plasmid. Three

344

independent experiments were performed (biological replicates), followed by reverse

345

transcription of the RNA and Illumina Sequencing. Analysis for differentially expressed genes

346

(DEGs, Supplemental Table 1) identified 2474 DEGs that are regulated consistently over all

347

three replicates (Figure 6A).

12

348

Clustering of DEGs according to Gene Ontology (GO) terms (Figure 6B) revealed that

349

Y37A1B.5 is involved in the regulation of metabolic processes, with sulfur compound

350

metabolism and lipid/carbohydrate metabolic processes in prominent positions among the

351

relevant GO terms.

352

The involvement of Y37A1B.5 in sulfur metabolic processes is expected for an ortholog of

353

SELENBP1 (see Introduction). Its role in lipid and carbohydrate metabolic processes is in line

354

with findings on the link between Selenbp1 with glucose/lipid metabolism in mice [35].

355 356

Y37A1B.5 knockdown-induced lifespan extension is independent of major stress-responsive

357

transcription factors

358

DAF-16 (the C. elegans ortholog of mammalian FOXO proteins) and SKN-1 (the Nrf2

359

ortholog) are among the most prominent transcription factors that are known to be involved

360

in the regulation of fuel (glucose/lipid) metabolism and stress response [36, 37]. Both

361

contribute to C. elegans resistance under various stress conditions, including exposure to

362

thiol-depleting agents [20]. Lifespan of DAF-16-deficient worms, i.e. daf-16(mu86) mutants

363

(see Figure 7A, Table 4), is lower than that of wildtype C. elegans, and Y37A1B.5 knockdown

364

extends lifespan to an extent similar to Y37A1B.5 knockdown in wildtype worms (Tables 2,

365

4). A similar effect is observed in our preliminary studies with SKN-1-deficient worms [skn-

366

1(zu135)] (n=1, >200 worms; Table 4, Figure S4). Unexpectedly, therefore, neither DAF-16

367

nor SKN-1 appear to be involved in the lifespan extension elicited by Y37A1B.5 knockdown

368

(Figure 7A, Table 4). Another major regulator of lipid metabolism, NHR-49, a transcription

369

factor analogous to mammalian hepatocyte nuclear factor 4 (HNF4) and peroxisome

370

proliferator-activated receptor α (PPARα), was demonstrated to also be involved in the C.

371

elegans response to oxidative stress [38]. In order to test for a requirement of NHR-49 for

372

lifespan extension by Y37A1B.5 knockdown we used NHR-49-deficient worms, nhr-

373

49(ok2165). Lifespan of these worms is significantly lower than that of wildtype C. elegans

374

(not shown), as previously described. Knockdown of Y37A1B.5 by RNAi, however, strongly

375

enhances mean and maximum lifespan of NHR-49-deficient worms (Figure 7B) by 27 to 36%

376

and 34 to 43%, respectively (Table 4), i.e. much higher than in daf-16(mu86) and skn-

377

1(zu135) mutants. This suggests that NHR-49, although not contributing to lifespan

378

extension elicited by Y37A1B.5 knockdown, antagonizes the lifespan extending effect of 13

379

Y37A1B.5 downregulation. Taken together, the transcription factors DAF-16 and NHR-49,

380

and likely also SKN-1, are not involved in the lifespan extension mediated by Y37A1B.5

381

knock-down.

382 383

Expression of Y37A1B.5 is modulated by transcriptional regulators MDT-15 and EGL-27

384

In order to identify transcriptional regulators of Y37A1B.5 expression, we focused on

385

two factors that are known to be involved in regulating C. elegans stress resistance and

386

lifespan, and, in part, affect lipid metabolism, MDT-15 and EGL-27 [39, 40]. MDT-15 is a

387

transcriptional coregulator known to be involved in the regulation of lipid metabolism [39]

388

and required for the C. elegans transcriptional response to (oxidative) stress as elicited by

389

exposure to paraquat or arsenite [41]. EGL-27 is a transcriptional regulator that was shown

390

to confer stress resistance, extending lifespan of C. elegans [40].

391

Using worms overexpressing pY37A1B.5::Y37A1B.5::gfp (Figure 3), we tested for an effect of

392

knocking down mdt-15 or egl-27 expression on Y37A1B.5 expression.

393

RNAi of egl-27 resulted in upregulation of Y37A1B.5::GFP production, implying that EGL-27 is

394

a negative regulator of Y37A1B.5 expression (Figure 8A). This is in line with the notion that

395

downregulation of Y37A1B.5 enhances stress resistance and lifespan of C. elegans. Y37A1B.5

396

was previously identified as an EGL-27 target gene whose expression levels are lower in EGL-

397

27-deficient cells, and that is upregulated by heat stress only in the presence of EGL-1 [40].

398

These data contradict our findings on the negative effect of EGL-27 on Y37A1B.5 levels. A

399

possible reason for these differences is that we analyzed for expression at the protein level

400

whereas the data by Xu and Kim [40] refer to analyses at the mRNA level. Another difference

401

is that we used RNAi-mediated downregulation of EGL-27, whereas Xu and Kim had EGL-27

402

expression completely inactivated.

403

Downregulation of MDT-15 using RNAi causes a robust downregulation of Y37A1B.5 (Figure

404

8B), suggesting it is directly involved in its transcriptional control. The knock-down of MDT-

405

15 would, according to our data, imitate the RNAi-induced downregulation of Y37A1B.5

406

eliciting an enhanced stress resistance (Figure 4) and extending lifespan (Figure 2).

407

Interestingly, MDT-15 appears to control the expression of lipid metabolism genes and the

14

408

nematodal oxidative stress response by interacting with both NHR-49 and SKN-1 [38, 41].

409

Knockdown of Y37A1B.5, however, did not affect mdt-15 or egl-27 mRNA levels (Figure 8C).

410

In summary, Y37A1B.5 expression is negatively regulated by EGL-27 and positively regulated

411

by MDT-15 (Figure 8D).

412 413

Conclusions

414

Y37A1B.5, a protein hitherto uncharacterized, is a C. elegans ortholog of SELENBP1 that

415

allows for a better survival of nematodes exposed to toxic selenite concentrations, while it is

416

dispensable for adult worms grown under standard laboratory conditions. In fact,

417

knockdown of Y37A1B.5 in young adult C. elegans even resulted in an increased lifespan and

418

resistance against oxidative stress. These effects are associated with changes in the C.

419

elegans transcriptome that suggest a contribution of sulfur metabolic processes and of fuel

420

metabolism. Surprisingly, the transcription factors DAF-16 and NHR-49, which are prominent

421

regulators of fuel metabolism and stress resistance in C. elegans, are not involved in the

422

lifespan extension mediated by Y37A1B.5 knockdown. However, we identify two novel

423

regulators of Y37A1B.5 expression, which is negatively regulated by EGL-27 and positively

424

regulated by MDT-15.

425

Our findings on Y37A1B.5 conferring selenite resistance, and its downregulation contributing

426

to oxidative stress resistance and lifespan extension are in line with observations on the

427

human ortholog: SELENBP1 sequesters supplemental Se, and its downregulation in tumor

428

cells decreases their sensitivity to cytotoxic effects of oxidative stressors such as H2O2 and

429

paraquat [42]. On the other hand, expression of Y37A1B.5 can be advantageous for free-

430

living nematodes, as they are widely spread geobionts and thus have to cope with large

431

variations in the Se content of soils world-wide, ranging from 0.01 to 1200 mg Se/kg [2].

432

Acknowledgements

433

This research was funded by Deutsche Forschungsgemeinschaft (DFG, Bonn, Germany)

434

through Research Training Group “ProMoAge” (RTG 2155, to C.K. and L.O.K.).

435

We gratefully acknowledge Dr. Karol Szafranski and the support by the Fritz Lipmann

436

Institute’s Core Facility Sequencing. 15

437

438

References

439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485

[1] Brigelius-Flohe, R.; Flohe, L. Selenium and redox signaling. Arch Biochem Biophys 617:48-59; 2017. [2] Fairweather-Tait, S. J.; Bao, Y.; Broadley, M. R.; Collings, R.; Ford, D.; Hesketh, J. E.; Hurst, R. Selenium in human health and disease. Antioxid Redox Signal 14:1337-1383; 2011. [3] Steinbrenner, H.; Speckmann, B.; Klotz, L. O. Selenoproteins: Antioxidant selenoenzymes and beyond. Arch Biochem Biophys 595:113-119; 2016. [4] Kryukov, G. V.; Castellano, S.; Novoselov, S. V.; Lobanov, A. V.; Zehtab, O.; Guigo, R.; Gladyshev, V. N. Characterization of mammalian selenoproteomes. Science 300:1439-1443; 2003. [5] Taskov, K.; Chapple, C.; Kryukov, G. V.; Castellano, S.; Lobanov, A. V.; Korotkov, K. V.; Guigo, R.; Gladyshev, V. N. Nematode selenoproteome: the use of the selenocysteine insertion system to decode one codon in an animal genome? Nucleic Acids Res 33:2227-2238; 2005. [6] Stenvall, J.; Fierro-Gonzalez, J. C.; Swoboda, P.; Saamarthy, K.; Cheng, Q.; Cacho-Valadez, B.; Arner, E. S.; Persson, O. P.; Miranda-Vizuete, A.; Tuck, S. Selenoprotein TRXR-1 and GSR-1 are essential for removal of old cuticle during molting in Caenorhabditis elegans. Proc Natl Acad Sci U S A 108:1064-1069; 2011. [7] Li, W.; Bandyopadhyay, J.; Hwaang, H. S.; Park, B. J.; Cho, J. H.; Lee, J. I.; Ahnn, J.; Lee, S. K. Two thioredoxin reductases, trxr-1 and trxr-2, have differential physiological roles in Caenorhabditis elegans. Mol Cells 34:209-218; 2012. [8] Boehler, C. J.; Raines, A. M.; Sunde, R. A. Deletion of thioredoxin reductase and effects of selenite and selenate toxicity in Caenorhabditis elegans. PLoS One 8:e71525; 2013. [9] Rohn, I.; Marschall, T. A.; Kroepfl, N.; Jensen, K. B.; Aschner, M.; Tuck, S.; Kuehnelt, D.; Schwerdtle, T.; Bornhorst, J. Selenium species-dependent toxicity, bioavailability and metabolic transformations in Caenorhabditis elegans. Metallomics 10:818-827; 2018. [10] Papp, L. V.; Lu, J.; Holmgren, A.; Khanna, K. K. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9:775-806; 2007. [11] Bansal, M. P.; Oborn, C. J.; Danielson, K. G.; Medina, D. Evidence for two selenium-binding proteins distinct from glutathione peroxidase in mouse liver. Carcinogenesis 10:541-546; 1989. [12] Steinbrenner, H.; Micoogullari, M.; Hoang, N. A.; Bergheim, I.; Klotz, L. O.; Sies, H. Seleniumbinding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biol 20:489-495; 2019. [13] Li, T.; Yang, W.; Li, M.; Byun, D. S.; Tong, C.; Nasser, S.; Zhuang, M.; Arango, D.; Mariadason, J. M.; Augenlicht, L. H. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol Nutr Food Res 52:1289-1299; 2008. [14] Elhodaky, M.; Diamond, A. M. Selenium-Binding Protein 1 in Human Health and Disease. Int J Mol Sci 19; 2018. [15] Raucci, R.; Colonna, G.; Guerriero, E.; Capone, F.; Accardo, M.; Castello, G.; Costantini, S. Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma. Biochim Biophys Acta 1814:513-522; 2011. [16] Schild, F.; Kieffer-Jaquinod, S.; Palencia, A.; Cobessi, D.; Sarret, G.; Zubieta, C.; Jourdain, A.; Dumas, R.; Forge, V.; Testemale, D.; Bourguignon, J.; Hugouvieux, V. Biochemical and biophysical characterization of the selenium-binding and reducing site in Arabidopsis thaliana homologue to mammals selenium-binding protein 1. J Biol Chem 289:31765-31776; 2014. [17] Wang, Y.; Fang, W.; Huang, Y.; Hu, F.; Ying, Q.; Yang, W.; Xiong, B. Reduction of seleniumbinding protein 1 sensitizes cancer cells to selenite via elevating extracellular glutathione: a novel mechanism of cancer-specific cytotoxicity of selenite. Free Radic Biol Med 79:186-196; 2015. [18] Pol, A.; Renkema, G. H.; Tangerman, A.; Winkel, E. G.; Engelke, U. F.; de Brouwer, A. P. M.; Lloyd, K. C.; Araiza, R. S.; van den Heuvel, L.; Omran, H.; Olbrich, H.; Oude Elberink, M.; Gilissen, C.; Rodenburg, R. J.; Sass, J. O.; Schwab, K. O.; Schafer, H.; Venselaar, H.; Sequeira, J. S.; Op den Camp, H. 16

486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536

J. M.; Wevers, R. A. Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis. Nat Genet 50:120-129; 2018. [19] Wei, Y.; Kenyon, C. Roles for ROS and hydrogen sulfide in the longevity response to germline loss in Caenorhabditis elegans. Proc Natl Acad Sci U S A 113:E2832-2841; 2016. [20] Urban, N.; Tsitsipatis, D.; Hausig, F.; Kreuzer, K.; Erler, K.; Stein, V.; Ristow, M.; Steinbrenner, H.; Klotz, L. O. Non-linear impact of glutathione depletion on C. elegans life span and stress resistance. Redox Biol 11:502-515; 2017. [21] Fraser, A. G.; Kamath, R. S.; Zipperlen, P.; Martinez-Campos, M.; Sohrmann, M.; Ahringer, J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408:325-330; 2000. [22] Brenner, S. The genetics of Caenorhabditis elegans. Genetics 77:71-94; 1974. [23] Zhang, Y.; Chen, D.; Smith, M. A.; Zhang, B.; Pan, X. Selection of reliable reference genes in Caenorhabditis elegans for analysis of nanotoxicity. PLoS One 7:e31849; 2012. [24] Bentley, D. R.; Balasubramanian, S.; Swerdlow, H. P.; Smith, G. P.; Milton, J.; Brown, C. G.; Hall, K. P.; Evers, D. J.; Barnes, C. L.; Bignell, H. R.; Boutell, J. M.; Bryant, J.; Carter, R. J.; Keira Cheetham, R.; Cox, A. J.; Ellis, D. J.; Flatbush, M. R.; Gormley, N. A.; Humphray, S. J.; Irving, L. J.; Karbelashvili, M. S.; Kirk, S. M.; Li, H.; Liu, X.; Maisinger, K. S.; Murray, L. J.; Obradovic, B.; Ost, T.; Parkinson, M. L.; Pratt, M. R.; Rasolonjatovo, I. M.; Reed, M. T.; Rigatti, R.; Rodighiero, C.; Ross, M. T.; Sabot, A.; Sankar, S. V.; Scally, A.; Schroth, G. P.; Smith, M. E.; Smith, V. P.; Spiridou, A.; Torrance, P. E.; Tzonev, S. S.; Vermaas, E. H.; Walter, K.; Wu, X.; Zhang, L.; Alam, M. D.; Anastasi, C.; Aniebo, I. C.; Bailey, D. M.; Bancarz, I. R.; Banerjee, S.; Barbour, S. G.; Baybayan, P. A.; Benoit, V. A.; Benson, K. F.; Bevis, C.; Black, P. J.; Boodhun, A.; Brennan, J. S.; Bridgham, J. A.; Brown, R. C.; Brown, A. A.; Buermann, D. H.; Bundu, A. A.; Burrows, J. C.; Carter, N. P.; Castillo, N.; Chiara, E. C. M.; Chang, S.; Neil Cooley, R.; Crake, N. R.; Dada, O. O.; Diakoumakos, K. D.; Dominguez-Fernandez, B.; Earnshaw, D. J.; Egbujor, U. C.; Elmore, D. W.; Etchin, S. S.; Ewan, M. R.; Fedurco, M.; Fraser, L. J.; Fuentes Fajardo, K. V.; Scott Furey, W.; George, D.; Gietzen, K. J.; Goddard, C. P.; Golda, G. S.; Granieri, P. A.; Green, D. E.; Gustafson, D. L.; Hansen, N. F.; Harnish, K.; Haudenschild, C. D.; Heyer, N. I.; Hims, M. M.; Ho, J. T.; Horgan, A. M.; Hoschler, K.; Hurwitz, S.; Ivanov, D. V.; Johnson, M. Q.; James, T.; Huw Jones, T. A.; Kang, G. D.; Kerelska, T. H.; Kersey, A. D.; Khrebtukova, I.; Kindwall, A. P.; Kingsbury, Z.; KokkoGonzales, P. I.; Kumar, A.; Laurent, M. A.; Lawley, C. T.; Lee, S. E.; Lee, X.; Liao, A. K.; Loch, J. A.; Lok, M.; Luo, S.; Mammen, R. M.; Martin, J. W.; McCauley, P. G.; McNitt, P.; Mehta, P.; Moon, K. W.; Mullens, J. W.; Newington, T.; Ning, Z.; Ling Ng, B.; Novo, S. M.; O'Neill, M. J.; Osborne, M. A.; Osnowski, A.; Ostadan, O.; Paraschos, L. L.; Pickering, L.; Pike, A. C.; Pike, A. C.; Chris Pinkard, D.; Pliskin, D. P.; Podhasky, J.; Quijano, V. J.; Raczy, C.; Rae, V. H.; Rawlings, S. R.; Chiva Rodriguez, A.; Roe, P. M.; Rogers, J.; Rogert Bacigalupo, M. C.; Romanov, N.; Romieu, A.; Roth, R. K.; Rourke, N. J.; Ruediger, S. T.; Rusman, E.; Sanches-Kuiper, R. M.; Schenker, M. R.; Seoane, J. M.; Shaw, R. J.; Shiver, M. K.; Short, S. W.; Sizto, N. L.; Sluis, J. P.; Smith, M. A.; Ernest Sohna Sohna, J.; Spence, E. J.; Stevens, K.; Sutton, N.; Szajkowski, L.; Tregidgo, C. L.; Turcatti, G.; Vandevondele, S.; Verhovsky, Y.; Virk, S. M.; Wakelin, S.; Walcott, G. C.; Wang, J.; Worsley, G. J.; Yan, J.; Yau, L.; Zuerlein, M.; Rogers, J.; Mullikin, J. C.; Hurles, M. E.; McCooke, N. J.; West, J. S.; Oaks, F. L.; Lundberg, P. L.; Klenerman, D.; Durbin, R.; Smith, A. J. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456:53-59; 2008. [25] Simpson, J. T.; Durbin, R. Efficient de novo assembly of large genomes using compressed data structures. Genome Res 22:549-556; 2012. [26] Kim, D.; Pertea, G.; Trapnell, C.; Pimentel, H.; Kelley, R.; Salzberg, S. L. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14:R36; 2013. [27] Liao, Y.; Smyth, G. K.; Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30:923-930; 2014. [28] Love, M. I.; Huber, W.; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550; 2014. 17

537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574

[29] Edgar, R.; Domrachev, M.; Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207-210; 2002. [30] Ying, Q.; Ansong, E.; Diamond, A. M.; Yang, W. A Critical Role for Cysteine 57 in the Biological Functions of Selenium Binding Protein-1. Int J Mol Sci 16:27599-27608; 2015. [31] Jacob, C.; Giles, G. I.; Giles, N. M.; Sies, H. Sulfur and selenium: the role of oxidation state in protein structure and function. Angew Chem Int Ed Engl 42:4742-4758; 2003. [32] Volz, J.; Bosch, F. U.; Wunderlin, M.; Schuhmacher, M.; Melchers, K.; Bensch, K.; Steinhilber, W.; Schafer, K. P.; Toth, G.; Penke, B.; Przybylski, M. Molecular characterization of metal-binding polypeptide domains by electrospray ionization mass spectrometry and metal chelate affinity chromatography. J Chromatogr A 800:29-37; 1998. [33] Hanschmann, E. M.; Godoy, J. R.; Berndt, C.; Hudemann, C.; Lillig, C. H. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal 19:1539-1605; 2013. [34] Fukasawa, K. M.; Hata, T.; Ono, Y.; Hirose, J. Metal preferences of zinc-binding motif on metalloproteases. J Amino Acids 2011:574816; 2011. [35] Ying, Q.; Ansong, E.; Diamond, A. M.; Lu, Z.; Yang, W.; Bie, X. Quantitative proteomic analysis reveals that anti-cancer effects of selenium-binding protein 1 in vivo are associated with metabolic pathways. PLoS One 10:e0126285; 2015. [36] Klotz, L. O.; Sanchez-Ramos, C.; Prieto-Arroyo, I.; Urbanek, P.; Steinbrenner, H.; Monsalve, M. Redox regulation of FoxO transcription factors. Redox Biol 6:51-72; 2015. [37] Yamamoto, M.; Kensler, T. W.; Motohashi, H. The KEAP1-NRF2 System: a Thiol-Based SensorEffector Apparatus for Maintaining Redox Homeostasis. Physiol Rev 98:1169-1203; 2018. [38] Goh, G. Y. S.; Winter, J. J.; Bhanshali, F.; Doering, K. R. S.; Lai, R.; Lee, K.; Veal, E. A.; Taubert, S. NHR-49/HNF4 integrates regulation of fatty acid metabolism with a protective transcriptional response to oxidative stress and fasting. Aging Cell 17:e12743; 2018. [39] Taubert, S.; Van Gilst, M. R.; Hansen, M.; Yamamoto, K. R. A Mediator subunit, MDT-15, integrates regulation of fatty acid metabolism by NHR-49-dependent and -independent pathways in C. elegans. Genes Dev 20:1137-1149; 2006. [40] Xu, X.; Kim, S. K. The GATA transcription factor egl-27 delays aging by promoting stress resistance in Caenorhabditis elegans. PLoS Genet 8:e1003108; 2012. [41] Hu, Q.; D'Amora, D. R.; MacNeil, L. T.; Walhout, A. J. M.; Kubiseski, T. J. The Caenorhabditis elegans Oxidative Stress Response Requires the NHR-49 Transcription Factor. G3 (Bethesda) 8:38573863; 2018. [42] Zhao, C.; Zeng, H.; Wu, R. T.; Cheng, W. H. Loss of Selenium-Binding Protein 1 Decreases Sensitivity to Clastogens and Intracellular Selenium Content in HeLa Cells. PLoS One 11:e0158650; 2016. [43] Sievers, F.; Higgins, D. G. Clustal Omega for making accurate alignments of many protein sequences. Protein Sci 27:135-145; 2018.

575 576

18

577

Legends to Figures

578 579

Fig. 1: Y37A1B.5 displays high sequence homology with SELENBP1.

580 581 582 583 584 585 586 587 588 589

Alignment of C. elegans Y37A1B.5 (NCBI Ref Seq#: NP_001255777.1) with human SELENBP1 (GenBank accession#: CAG33133.1) and orthologs from Danio rerio (NCBI Ref Seq#: NP_956864.1) and Drosophila melanogaster (LP16180p; GenBank accession#: AAV36940.1). The alignment identifies 52% identical aminoacyl residues for SELENBP1 and Y37A1B.5. Asterisk (*): fully conserved residue; colon(:): conservation between groups of strongly similar properties, Gonnet PAM 250 matrix > 0.5; period(.): conservation of weakly similar properties between groups, Gonnet PAM 250 matrix < 0.5. Multiple sequence alignment was performed using CLUSTAL O(1.2.4) [43]. Selected conserved motifs are highlighted as follows: Cys57, highlighted in black; thioredoxin motif (CxxC, transparent box); histidinecontaining metal binding motifs (HxD, HxxH, gray background); see text for details.

590 591

Fig. 2: Y37A1B.5 mRNA levels decrease with age and its downregulation increases lifespan.

592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610

(A) Relative Y37A1B.5 mRNA levels of N2 wild-type worms after 1, 3, 5, 7, 10 or 20 days, starting 64 h after synchronization, as determined in three independent experiments using qRT-PCR. Data were first normalized to mRNA levels of the housekeeping gene and then against the expression level of day 1. Data shown are relative means ± SD. (**p<0.01 vs. control; unpaired t-test). (B) Exponential regression of data from graph (A). Data shown are means ± 95% confidence band. (C) Survival of nematodes depleted of Y37A1B.5 through RNAi (p<0.0001 vs. control, log-rank test). Age-synchronized young adult worms were treated with Y37A1B.5 or control RNAi. Survival was monitored daily until the end of the reproduction period and every second day thereafter. The lifespan experiment was conducted in quintuplicates and was performed four independent times (for details, see Table 2). One representative experiment is shown. (D) Relative mean and maximum lifespan of four independent lifespan experiments with Y37A1B.5 RNAi or control. Data were normalized to mean or maximum lifespan of respective control experiment (**p<0.01 vs. control; unpaired t-test). (E) Relative Y37A1B.5 mRNA levels after three or five days of Y37A1B.5 RNAi or control, starting at the young adult stage, as determined in three independent experiments using qRT-PCR. Data shown are relative means + SD. (***p<0.001 vs. respective control; t-test) (F) Toxicity of different selenite concentrations to C. elegans following RNAi using control or Y37A1B.5-specific plasmids (***p<0.001, **p<0.01 vs. control; unpaired t-test).

611 612

Fig. 3: Y37A1B.5 is a cytoplasmic protein expressed in hypodermal cells.

613 614 615 616

(A) Schematic representation of the translational reporter construct used in this study, pY37A1B.5::Y37A1B.5::gfp. (B) Hypodermal localisation of Y37A1B.5::GFP. (C) Subcellularly, Y37A1B.5::GFP is localized primarily in the cytoplasm. White arrows indicate nuclei devoid of signal. (D) Few worms display fluorescence in anterior (arrows) or posterior (not shown) 19

617 618

intestinal cells. (E) Comparison of RNAi using control or Y37A1B.5-specific plasmids on Y37A1B.5::GFP reporter strain. Dashed white lines indicate worm shape.

619 620

Fig. 4: Y37A1B.5 is involved in the stress response of C. elegans.

621 622 623 624 625 626 627 628 629 630

(A) N2 wildtype worms (young adult; 64h after synchronisation) were fed with Y37A1B.5 RNAi or control bacteria for 144 h and then exposed to 300 mM of paraquat for 10 hours. Survival was scored every hour. (***p<0.0001 vs. control, log-rank test). (B) Relative mean survival of Y37A1B.5 RNAi or control worms on 300 mM paraquat resulting from four independent experiments. Data were normalized to mean survival of control (*p<0.05 vs. control, Mann-Whitney test). (C) Y37A1B.5::GFP signals in young adult worms (64h after synchronisation) that were exposed to arsenite for 24 h. Each data point represents Y37A1B.5::GFP signal/worm in arbitrary units for one individual worm (*p<0.05, ***p<0.001; unpaired t-test). (D) Examples of worms evaluated in Figure 4C (green, red data points), representing worms exposed to 0 µM (green box) and 100 µM (red box) arsenite.

631 632

Fig. 5: Y37A1B.5 downregulation improves C. elegans health parameters.

633 634 635 636 637 638 639 640 641 642 643 644 645 646 647

(A) Motility of young adult worms after 10 days of RNAi treatment (Y37A1B.5 RNAi vs. control); movements of individual worms were captured by a camera and distances covered per 10 s calculated using a tracking software. For an individual experiment, 10 worms were analyzed per group; three independent experiments were performed (*p<0.05, paired ttest). (B) Progeny per worm depleted of Y37A1B.5 through RNAi. 64 h after synchronization worms were transferred to RNAi plates. Each day, single worms were transferred to a new agar plate until nematodes ceased to lay eggs. Worms were allowed to hatch from the eggs and to grow until reaching the L3 larval stage before being counted. The experiment was conducted in quintuplicates and performed three independent times (p>0.05 vs. control; paired t-test). (C) Body length [µm] per worm (*p<0.05, paired t-test) and (D) body area [µm²] per worm after Y37A1B.5 RNAi. Young adult worms were exposed to control or Y37A1B.5-specific RNAi for 5 or 7 days. Pictures were taken and worms were measured using NIS elements software (Nikon). 10 worms were analyzed for each treatment group, and the experiment was repeated twice (7d) or three times (5d). Data shown are means ± SD (statistical analysis: paired t-test).

648 649

Fig. 6: RNA-Seq analysis of transcriptome changes induced by Y37A1B.5 knockdown.

650 651 652 653 654 655

(A) Heat map of individual expression values of all 2474 differentially expressed genes (adjusted p-value < 0.05). Prior to heat map calculation, raw read counts were size-factor normalized (DESeq2, v. 1.16.1). The color scale represents row z-score. Hierarchical clustering of the samples or DEGs is represented by dendrograms at the top and left, respectively. (B) GSEA analysis for GO biological processes using WebGestalt 2019, with fold changes of differentially expressed genes indicated as rank. Analysis was performed using 20

656 657

standard settings. Black (positive) or grey (negative) bars show “up-“ or “downregulated” GO terms according to normalized enrichment scores (NES).

658 659 660

Fig. 7: Lifespan extension elicited by depletion of Y37A1B.5 is independent of transcription factors DAF-16 and NHR-49.

661 662 663 664 665

Age-synchronized nematodes were treated with Y37A1B.5 RNAi or control throughout their lifespan, starting 64h hours after synchronization. Survival rates of (A) daf-16(mu86) and (B) nhr-49(ok2165) nematodes were monitored daily for survival until the end of the reproduction period and every second day thereafter. P values were determined by log-rank test. Representative survival curves are depicted (for details, see Table 4).

666 667

Fig. 8: MDT-15 and EGL-27 modulate the expression of Y37A1B.5.

668 669 670 671 672 673 674 675

(A, B) Young adult worms overexpressing pY37A1B.5::Y37A1B.5::gfp (see Figure 3) were treated for 5 days, using control plasmids or (A) egl-27-specific or (B) mdt-15-specific RNAi plasmids. Each data point represents Y37A1B.5::GFP expression/worm in arbitrary units for one individual worm. Right panels show examples of worms evaluated, representing worms exposed to control (green box) or target-specific RNAi plasmids (red box). Dashed white lines indicate shapes of worms. (C) Expression of egl-27 and mdt-15 at day 5 of Y37A1B.5 knockdown, as evaluated by qRT-PCR and RNA-Seq, respectively. (D) Schematic representation of MDT-15 and EGL27 regulation of Y37A1B.5 expression.

676

21

677

Tables

678 679 680

Table 1: Primer pairs used for qPCR analyses Gene

Accession No.

name

or Reference

Forward primer

Reverse primer

Y37A1B.5 NM_001268848.1 TTTTAGAATTCATCCTGTTGAGGAG AAGAGCCCATCCACTTACTTTTT mdt-15

NM_171134.6

ACGACAGCAGGAAACACTCC

TGATGGAGCAGGCAATCCTC

egl-27

NM_171011.3

CCATCAGGAAGAGCGTGTCA

CACGCTGGAACTTGAGATGG

cdc-42

[23]

AGCCATTCTGGCCGCTCTCG

GCAACCGCTTCTCGTTTGGC

tba-1

[23]

TCAACACTGCCATCGCCGCC

TCCAAGCGAGACCAGGCTTCAG

pmp-3

[23]

TGGCCGGATGATGGTGTCGC

ACGAACAATGCCAAAGGCCAGC

681 682

22

Exp. No.

Strain, Treatment

Effect on Life Span

P (vs. b Ctrl)

Median Life Span (Days)

Mean Life Span c (Days ± SEM)

Mean Life Span (%)

Max Life Span Max Life Span No. of Uncenc (Days ± SEM) (%) sored Worms

Total Number of Worms

18

19.0 ± 0.1

100

22.0 ± 0.6

100

184

394

20

20.5 ± 0.2

107.7

24.0 ± 0.8

109.1

218

382

20

20.0 ± 0.1

100

24.0 ± 0.6

100

332

400

22

22.2 ± 0.1

111.3

28.0 ± 1.0

116.7

359

400

20

19.4 ± 0.1

100

22.8 ± 0.4

100

284

400

20

20.2 ± 0.2

104.4

24.8 ± 0.7

108.8

320

400

18

18.9 ± 0.2

100

24.0 ± 0.8

100

283

400

22

21.8 ± 0.3

115.2

28.0 ± 1.0

116.7

365

400

20

20.3 ± 0.2

100

24.4 ± 1.0

100

249

400

20

20.4 ± 0.3

100.9

26.4 ± 1.0

108.2

335

400

18

17.9 ± 0.3

100

21.6 ± 0.4

100

324

400

18

18.8 ± 0.1

104.9

25.2 ± 0.4

116.7

362

400

Knockdown of Y37A1B.5 (starting at young adult stage) 1 (see Fig. 2C)

N2 / L4440

N2 /
Y37A1B.5 N2 / L4440 2 N2 /
Y37A1B.5 N2 / L4440 3 N2 /
Y37A1B.5 N2 / L4440 4 N2 /
Y37A1B.5 Knockdown of Y37A1B.5 (starting at egg) N2 / L4440 1 N2 / = Y37A1B.5 N2 / L4440 2 N2 /
Y37A1B.5

****

****

****

****

n.s.

****

Table 2: Statistics for RNAi knockdown of Y37A1B.5a a

Survival curves for all experiments are provided in supplemental Figures S1 and S2

b

Control: N2 / L4440; **** P<0.0001; n.s., not significant

c

5 technical replicates

Exp. No.

Strain, Treatment

Effect on Survival

P (vs. Ctrl)

a

Median Survial (h)

N2 / L4440 1

N2 / Y37A1B.5

=

p = 0.0556

N2 / L4440 2

3 (see Fig.4A)

N2 / Y37A1B.5




****

N2 / L4440 N2 / Y37A1B.5




***

N2 / L4440

Mean Survival (h ± Mean Survival (%) SEM)

No. of Uncensored Worms

Total No. of Worms

5

5.6 ± 0.2

100

69

80

6

6.2 ±0.1

109.9

38

49

4

5.5 ± 0.2

100

66

79

9

8.0 ± 0.2

146.9

44

81

7

7.1 ± 0.2

100

70

78

9

8.2 ± 0.2

116.8

53

76

8

7.8 ± 0.2

100

81

90

10

8.8 ± 0.2

112.8

50

85

4 N2 / Y37A1B.5




****

Table 3: Statistics for stress resistance analysis against paraquat after Y37A1B.5 RNAi a

Controls: N2 / L4440; ***P<0,001 ****P<0.0001; n.s., not significant

Exp. No.

Strain, Effect on P (vs. b Treatment Life Span Ctrl) Knockdown of Y37A1B.5 in daf-16 (mu86) daf-16 / L4440 1 (see Fig. 7A) daf-16 / ****
Y37A1B.5 daf-16 / L4440 2 daf-16 / ****
Y37A1B.5 Knockdown of Y37A1B.5 in skn-1 (zu135) skn-1 / L4440 1 skn-1 / ****
Y37A1B.5 Knockdown of Y37A1B.5 in nhr-49 (ok2165) nhr-49 / L4440 1 nhr-49 / ****
Y37A1B.5 nhr-49 / L4440 2 (see Fig. 7B) nhr-49 / ****
Y37A1B.5 nhr-49 / L4440 3 nhr-49 / ****
Y37A1B.5

Median Life Span (Days)

Mean Life Span c (Days ± SEM)

Mean Life Span (%)

18

17.6 ± 0.0

100

20.8 ± 0.4

100

311

400

20

19.3 ± 0.1

109.9

22.4 ± 0.4

107.7

370

400

18

18.9 ± 0.1

100

22.0 ± 0.0

100

225

450

20

19.8 ± 0.2

104.6

24.0 ± 0.8

109.1

259

450

17

17.4 ± 0.1

100

19.8 ± 0.4

100

210

231

19

19.2 ± 0.2

110

25.8 ± 0.7

130.3

204

230

16

15.8 ± 0.2

100

20.0 ± 0.0

100

248

400

20

20.1 ± 0.3

127.4

26.4 ± 0.7

132.0

283

400

16

15.9 ± 0.1

100

19.2 ± 0.4

100

321

400

22

21.6 ± 0.1

136.5

28.0 ± 0.0

145.8

295

400

16

15.4 ± 0.3

100

20.0 ± 0.0

100

298

316

20

20.9 ± 0.2

135.3

27.5 ± 0.4

137.5

300

320

Table 4: Statistics for RNAi knockdown of Y37A1B.5 in knockout mutants a a

Survival curves for all experiments are provided in supplemental Figures S1 and S2

Max Life Span Max Life Span No. of Uncenc (days ± SEM) (%) sored Worms

Total Number of Worms

b

Controls: daf-16 / L4440; skn-1 / L4440; nhr-49 / L4440; **** P<0.0001

c

4-5 technical replicates

Figure 1

C. H. D. D.

elegans sapiens rerio melanogaster

-----MSPNCGLKCHGGPGYASPADAIK-GPREEVLFVTAP---NAADGPDAIFTVDVNP -----MATKCG---NCGPGYSTPLEAMK-GPREEIVYLPCIYRNTGTEAPDYLATVDVDP -----MASTCS---GCGPGYKTPLDAMK-GPREEIVYLPCIYRNTDIQKPDYLATVDINP STHNNRQAMSNKTCCRGPGYATPLDAMRSGPREKLLYTVTVQPNLDEPHGDYLSTVDVDP .. **** :* :*:: ****:::: * : ***::*

51 51 51 60

C. H. D. D.

elegans sapiens rerio melanogaster

ESDTFCQVISRVDVPHIGDEVHHTGWNACSSCHDK-----PTEKRSHLIVPCLNSDRIYI KSPQYCQVIHRLPMPNLKDELHHSGWNTCSSCFGD-----STKSRTKLVLPSLISSRIYV QSPNFCKVIHRLPMPNLKDELHHSGWNACSSCFDD-----PSKRRNRLILPSLISSRIYV ESPTYCQIVHRTFTNRKGDELHHSGWNACSSCYYVDESSKTVPKRDRLVLPSLNSDFIYI :* :*::: * . **:**:***:****. * :*::*.* *. **:

106 106 106 120

C. H. D. D.

elegans sapiens rerio melanogaster

INVENERK-IYLEHTIEPSKLH-SLNLSFPHTSHCLADGNIMISTLGEANGTPSGNFLLL VDVGSEPRAPKLHKVIEPKDIHAKCELAFLHTSHCLASGEVMISSLGDVKGNGKGGFVLL VDVGTDPRAPRLHKTVEPTDLFWKCGLANPHTSHCLGSGQIMISTMGDPSGNGKGGFVLL LDVVTDPRKPEIVKTIDGDVLK-SHNVTAPHTTHCLANGNIMISVMGDAEGYAKGDFILF ::* .: : : :.:: : . :: **:***..*::*** :*: .* .*.*:*:

164 166 166 179

C. H. D. D.

elegans sapiens rerio melanogaster

DGKTFEPKGTWPADEKTVPFNYDFWYQPRRNVMISTEWGSPNHIKKGFNPAHVG-EGLYG DGETFEVKGTWERPGGAAPLGYDFWYQPRHNVMISTEWAAPNVLRDGFNPADVE-AGLYG DGETFEVIGNWEQPGDAAPFGYDFWYQPRHNVMISTEWGAPKALGNGFNPADVK-AGHYG DS-DFNCIGTWTKGDKKALCGYDFWYQPYFDVMVSSEWGAPNKWRRGWKNVDLEDMSQYG *. *: *.* . .******* :**:*:**.:*: *:: ..: . **

223 225 225 238

C. H. D. D.

elegans sapiens rerio melanogaster

NSVHIFEWDSKKYLQTIDLPQPLGALPLEVRFLHEPTSEHAFVGCALGSGIFRIHPVEEN SHLYVWDWQRHEIVQTLSLK--DGLIPLEIRFLHNPDAAQGFVGCALSSTIQRFYKNEGG QRLHVWDWTTHKRIQTLDLGE-EGAIPLEVRFLHDPAAAEGFVGCALQSTVFRFYKTPKG CRLNFYKWSTQTLYQTIDLGS-DGITPLEIRFLHNPKKAEGFVGCALNAKVFHFKKKSD: .:.* : **:.* * ***:****:* ..****** : : ::

283 283 284 296

C. H. D. D.

elegans sapiens rerio melanogaster

STTHAATLVAFIPSKKVSG--WALPEMPALITDILISMDDRFLYVSCWLHGDIRQYDISD --TWSVEKVIQVPPKKVKG--WLLPEMPGLITDILLSLDDRFLYFSNWLHGDLRQYDISD --DWAAEKVIKVPSKKVEG--WALPDMPGLITDILISLDDRFLYFSNWLHGDIRQYDITD SDEFEAKKVIDIPGKLVDTGSGVAEDMGGMISDIIISLDDRFLYVNCWRHGDVRQYDITD . * :* * *. :* .:*:**::*:******.. * ***:*****:*

341 339 340 356

C. H. D. D.

elegans sapiens rerio melanogaster

PLKVKLNSQVYIGGSVHTESN-VKVLEGEK---PIEALYVKGRKIEGGPQMLQLSLDGKR PQRPRLTGQLFLGGSIVKGGP-VQVLEDEELKSQPEPLVVKGKRVAGGPQMIQLSLDGKR RKNPRMVGQVFLGGSVLKDGP-VKVLEDKELDSQPTPRILK----------------GKR PENPKLTGQLFLGGAICSDLPNVIVKEDKELKERPPARYVKGRRLEGGPQMLQLSLDGKR . :: .*:::**:: . * * *.:: :* ***

397 398 383 416

C. H. D. D.

elegans sapiens rerio melanogaster

LYVTTSLYKKWDDQFYPEHVKSGATMVQVNIDPESGKMEINRDFLIDFGKIEGGPYLAHE LYITTSLYSAWDKQFYPDLIREGSVMLQVDVDTVKGGLKLNPNFLVDFGKEPLGPALAHE LYVTTSLYSAWDKQFYPDLIKEGSVMMQIDVNTDTGGLKLNENFLVDFGAEPEGPALAHE LYVSSSLYSPWDKQFYPKMVSQGGHIVLIDVDTVNGGISLNEDFLVDFANEPYGPSLPHE **:::***. **.****. : .*. :: :::: .* :.:* :**:**. ** * **

457 458 443 476

C. H. D. D.

elegans sapiens rerio melanogaster

MRYPGGDCTSDIWI---LRYPGGDCSSDIWI---LRYPGGDCTSDIWL---MRYPGGDCTSDIWLANDA :*******:****:

471 472 457 494

Figure 2

A

B

1.25

Y37A1B.5

Rel. mRNA level

1.00

R2 = 0.8785

0.75 0.50 0.25 0.00 0

5

10

15

20

Time (days after adulthood)

D

E Rel. mRNA level [fold]

C

Percent alive (0 mM selenite = 100)

F

50 40

n=6

Ctr RNAi Y37 RNAi

30 20

25 20

n=3

Ctr RNAi Y37 RNAi

15

**

10

10 5

0

**

0 20 mM Na-Selenite

30 mM Na-Selenite

Figure 3

A

B

C

E

D

Ctr RNAi

Y37 RNAi

Y37::gfp expression / worm

Survival [%]

Figure 4

A B

C D

0 Arsenite (µM) 100

Figure 5

A

Body length / worm [µm x 103]

C

Ct

i Y3

7R

i NA

r Ct

D

A RN

i

7R Y3

i NA

14

Body area / worm [µm2 x 104]

Progeny / worm

B

NA rR

7d p = 0.0544

12

10

8

i NA rR Ct

i NA 7R Y3

Figure 6

Figure 7

A

B

Figure 8

Ctr RNAi

egl-27 RNAi

Y37::gfp expression / worm

A

C

200 175 150

Y37A1B.5 RNAi control

ns

125

egl-27

mdt-15

ns

100 75 50 25 0 qPCR

Ctr RNAi Y37::gfp expression / worm

B

mdt-15 RNAi

D

MDT-15

RNA-Seq

EGL-27

Y37A1B.5

HIGHLIGHTS •

Y37A1B.5 is a C. elegans ortholog of human selenium binding protein 1 (SELENBP-1)

•

Y37A1B.5 is a cytoplasmic protein predominantly expressed in hypodermal cells

•

Y37A1B.5 knockdown by RNAi causes C. elegans (mean and maximum) lifespan extension

•

Y37A1B.5 enhances selenite resistance but sensitizes towards oxidative stress

•

Expression of Y37A1B.5 is modulated by MDT-15 and EGL-27